Research Article

You have free access to this content

Growth effects of methylphenidate among childhood cancer survivors: A 12-month case-matched open-label study

  1. Bruce W. Jasper PhD1,
  2. Heather M. Conklin PhD1,*,
  3. Joanne Lawford PhD1,
  4. E. Brannon Morris MD2,
  5. Scott C. Howard MD3,
  6. Shengjie Wu MS4,
  7. Xiaoping Xiong PhD4,
  8. John Shelso MD5,
  9. Raja B. Khan MD6

Article first published online: 14 OCT 2008

DOI: 10.1002/pbc.21770

Issue

Pediatric Blood & Cancer

Pediatric Blood & Cancer

Volume 52, Issue 1, pages 39–43, January 2009

Additional Information

How to Cite

Jasper, B. W., Conklin, H. M., Lawford, J., Morris, E. B., Howard, S. C., Wu, S., Xiong, X., Shelso, J. and Khan, R. B. (2009), Growth effects of methylphenidate among childhood cancer survivors: A 12-month case-matched open-label study. Pediatr. Blood Cancer, 52: 39–43. doi: 10.1002/pbc.21770

Author Information

  1. 1

    Division of Behavioral Medicine, University of Tennessee, St. Jude Children's Research Hospital, Memphis, Tennessee

  2. 2

    Division of Neurology, University of Tennessee, St. Jude Children's Research Hospital, Memphis, Tennessee

  3. 3

    Department of Oncology, University of Tennessee, St. Jude Children's Research Hospital, Memphis, Tennessee

  4. 4

    Department of Biostatistics, University of Tennessee, St. Jude Children's Research Hospital, Memphis, Tennessee

  5. 5

    Division of Endocrinology, University of Tennessee, St. Jude Children's Research Hospital, Memphis, Tennessee

  6. 6

    Department of Neurology, University of Tennessee, Memphis, Tennessee

*Division of Behavioral Medicine, St. Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105-2794.

Publication History

  1. Issue published online: 12 NOV 2008
  2. Article first published online: 14 OCT 2008
  3. Manuscript Accepted: 14 AUG 2008
  4. Manuscript Received: 27 MAR 2008

Funded by

  • National Cancer Institute. Grant Numbers: P30 CA21765, R01CA078957, U01 CA81445
  • American Lebanese Syrian Associated Charities (ALSAC)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (110K)

REFERENCES

  • 1
    Ris MD, Noll RB. Long-term neurobehavioral outcome in pediatric brain-tumor patients: Review and methodological critique. J Clin Exp Neuropsychol 1994; 16: 21–42.
  • 2
    Rodgers J, Horrocks J, Britton PG, et al. Attentional ability among survivors of leukaemia. Arch Dis Child 1999; 80: 318–323.
  • 3
    Schatz J, Kramer JH, Ablin A, et al. Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 2000; 14: 189–200.
  • 4
    Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000; 15: 603–630.
  • 5
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association; 1994.
  • 6
    MTAC Group. National institute of mental health multimodal treatment study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics 2004; 113: 762–769.
  • 7
    Brown RT, Amler RW, Freeman WS, et al. Treatment of attention-deficit/hyperactivity disorder: Overview of the evidence. Pediatrics 2005; 115: e749–e757.
  • 8
    Swanson J, Greenhill L, Wigal T, et al. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry 2006; 45: 1304.
  • 9
    Conklin HM, Khan RB, Reddick WE, et al. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: A randomized, double-blind, cross-over trial. J Pediatr Psychol 2007; 32: 1127–1139.
  • 10
    Mulhern RK, Khan RB, Kaplan S, et al. Short-term efficacy of methylphenidate: A randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 2004; 22: 4795–4803.
  • 11
    Thompson SJ, Leigh L, Christensen R, et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol 2001; 19: 1802–1808.
  • 12
    Pliszka SR, Matthews TL, Braslow KJ, et al. Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006; 45: 520–526.
  • 13
    Charach A, Figueroa M, Chen S, et al. Stimulant treatment over 5 years: Effects on growth. J Am Acad Child Adolesc Psychiatry 2006; 45: 415–421.
  • 14
    Poulton A. Growth on stimulant medication; clarifying the confusion: A review. Arch Dis Child 2005; 90: 801–806.
  • 15
    Brownstein CM, Mertens AC, Mitby PA, et al. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: A report from the childhood cancer survivor study. J Clin Endocrinol Metab 2004; 89: 4422–4427.
  • 16
    Gurney JG, Ness KK, Stovall M, et al., Final height and body mass index among adult survivors of childhood brain cancer: Childhood cancer survivor study. J Clin Endocrinol Metab 2003; 88: 4731–4739.
  • 17
    Katz JA, Pollock BH, Jacaruso D, et al. Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia. J Pediatr 1993; 123: 546–552.
  • 18
    Weber P, Lutschg J. Methylphenidate treatment. Pediatr Neurol 2002; 26: 261–266.
  • 19
    Conners CK. Conners' rating scales-revised technical manual. North Tonawanda, New York: Multi Health Systems; 2000.
  • 20
    Kuczmarski RJ, Ogden CL, Guo SS, et al., CDC growth charts for the United States: Methods and development. Vital Health Stat 11 2002; 246: 1–190.
  • 21
    Littell RC, Milliken GA, Stoup WW, et al. SAS System for Mixed Models. Cary, NC: SAS Institute; 1996.
  • 22
    Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer 2004; 11: 589–602.
  • 23
    Safer DJ, Allen RP. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Pediatrics 1973; 51: 660–667.
  • 24
    Mattes JA, Gittelman R. Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 1983; 40: 317–321.
View Full Article (HTML) Get PDF (110K)